What are the most common metastatic sites of ovarian cancer and the typical routes of spread (transcoelomic, lymphatic, hematogenous)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Metastatic Sites and Routes of Spread in Ovarian Cancer

Ovarian cancer spreads primarily via transcoelomic (peritoneal) dissemination, with the most common metastatic sites being the peritoneum, omentum, diaphragm, and pelvic structures, while lymphatic spread to retroperitoneal nodes occurs in over 50% of cases and hematogenous metastasis is the least common route.

Primary Routes of Metastatic Spread

Transcoelomic (Peritoneal) Spread - Most Common Route

Transcoelomic metastasis is the predominant mechanism of dissemination and is responsible for the greatest morbidity and mortality in ovarian cancer. 1, 2

The most common sites of intraperitoneal seeding include: 3

  • Pelvis (pelvic peritoneum, uterus, fallopian tubes)
  • Omentum (frequently involved)
  • Paracolic gutters
  • Liver capsule (superficial metastases)
  • Diaphragm (particularly right hemidiaphragm)
  • Small bowel and mesentery

The disease spreads by direct extension, exfoliation of tumor cells into the peritoneal space, and dissemination along peritoneal fluid flow pathways. 3 Peritoneal involvement is present in approximately 70% of patients at initial diagnosis. 3

Lymphatic Spread - Second Most Common Route

Ovarian cancer spreads via lymphatics directly to pelvic nodes, para-aortic nodes, or both simultaneously with peritoneal dissemination. 4

Lymph node involvement rates: 4

  • Pelvic lymph nodes: Positive in 57.9% of all stages (70.4% in Stage III)
  • Para-aortic lymph nodes: Positive in 50.9% overall (67.6% in Stage III)
  • Concomitant involvement: 40.4% of patients with positive pelvic nodes also have positive para-aortic nodes
  • Skip metastases: 10.5% have positive para-aortic nodes with negative pelvic nodes

There is significant association between diaphragmatic involvement and retroperitoneal node metastases—84.4% of patients with diaphragmatic deposits also have positive retroperitoneal nodes. 4 This demonstrates that ovarian cancer spreads almost simultaneously via both intra-abdominal and retroperitoneal routes. 4

Hematogenous Spread - Least Common Route

Hematogenous metastasis occurs but is substantially less common than transcoelomic or lymphatic spread. 1, 2, 5

Distant hematogenous metastases (Stage IV disease) include: 6

  • Parenchymal liver metastases (as opposed to capsular involvement, which is Stage III)
  • Lung parenchyma
  • Extra-abdominal organs
  • Pleural effusion with positive cytology (Stage IVA)
  • Inguinal lymph nodes and lymph nodes outside the abdominal cavity (Stage IVB)

Recent evidence has identified hematogenous metastasis to the omentum via circulating tumor cells, challenging the traditional view that all omental metastases occur via passive peritoneal fluid transport. 5

Staging Implications Based on Metastatic Sites

Stage III disease (most common at diagnosis) includes: 6

  • Peritoneal implants outside the pelvis
  • Positive retroperitoneal lymph nodes
  • Superficial liver metastases (capsular involvement)
  • Extension to liver or spleen capsule without parenchymal involvement

Stage IV disease includes: 6

  • Parenchymal liver or splenic metastases
  • Extra-abdominal metastases
  • Pleural effusion with positive cytology

Clinical Implications for Surgical Staging

Comprehensive surgical staging must address both intra-abdominal and retroperitoneal spread patterns. 4 Required staging procedures include: 6

  • Biopsy of diaphragmatic peritoneum
  • Paracolic gutter biopsies
  • Pelvic peritoneum assessment
  • Complete pelvic and para-aortic lymphadenectomy (critical given high nodal involvement rates)
  • Infracolic omentectomy
  • Peritoneal washings from all four quadrants
  • Appendectomy for mucinous tumors (8% have appendiceal involvement) 7

Common pitfall: Up to 31% of apparent early-stage ovarian cancers are upstaged with proper surgical staging, with the most common sites of occult disease being pelvic peritoneum, ascites, para-aortic nodes, and diaphragm. 6

References

Research

Ovarian carcinomatosis: how the radiologist can help plan the surgical approach.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2012

Research

The spread of ovarian cancer.

Bailliere's clinical obstetrics and gynaecology, 1989

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Mucinous Ovarian Tumors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.